Home/Filings/4/0001773751-25-000133
4//SEC Filing

Baird Melissa 4

Accession 0001773751-25-000133

CIK 0001773751other

Filed

Apr 22, 8:00 PM ET

Accepted

Apr 23, 4:21 PM ET

Size

15.0 KB

Accession

0001773751-25-000133

Insider Transaction Report

Form 4
Period: 2025-04-21
Baird Melissa
Chief Operating Officer
Transactions
  • Exercise/Conversion

    Class A Common Stock

    2025-04-21$2.43/sh+10,765$26,159838,416 total
  • Exercise/Conversion

    Stock Option (right to buy)

    2025-04-2110,765727,128 total
    Exercise: $2.43Exp: 2030-05-13Class A Common Stock (10,765 underlying)
  • Exercise/Conversion

    Stock Option (right to buy)

    2025-04-2122,5680 total
    Exercise: $1.75Exp: 2029-11-06Class A Common Stock (22,568 underlying)
  • Exercise/Conversion

    Class A Common Stock

    2025-04-21$1.75/sh+22,568$39,494827,651 total
  • Sale

    Class A Common Stock

    2025-04-21$25.66/sh27,035$693,683811,381 total
  • Sale

    Class A Common Stock

    2025-04-21$26.29/sh6,298$165,573805,083 total
Footnotes (5)
  • [F1]The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 26, 2024 by the Reporting Person.
  • [F2]Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $25.29 - $25.98. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
  • [F3]Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $26.055 - $26.69. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
  • [F4]Prior to the Company's business combination transaction in 2021, the option represented the right to purchase 250,000 shares of Hims, Inc., with an exercise price of $0.79. Following the Company's business combination transaction in 2021, the option converted into the right to purchase 113,245 shares of the Company with an exercise price of $1.75. 100% of the shares subject to the option have vested.
  • [F5]Prior to the Company's business combination transaction in 2021, the option represented the right to purchase 1,719,884 shares of Hims, Inc., with an exercise price of $1.10. Following the Company's business combination transaction in 2021, the option converted into the right to purchase 779,073 shares of the Company with an exercise price of $1.75. 100% of the shares subject to the option have vested.

Issuer

Hims & Hers Health, Inc.

CIK 0001773751

Entity typeother

Related Parties

1
  • filerCIK 0001837815

Filing Metadata

Form type
4
Filed
Apr 22, 8:00 PM ET
Accepted
Apr 23, 4:21 PM ET
Size
15.0 KB